6. Literaturverzeichnis

1. Wechsler JG (Herausgeber). Adipositas - Ursachen und Therapie. Blackwell Verlag GmbH Berlin 2003.

2. Wirth A (Herausgeber). Adipositas-Fibel. Springer-Verlag Berlin-Heidelberg 1998.

3. Stich V und Berlan M. Physiological regulation of NEFA availability: lipolysis pathway. Proc Nutr Soc 2004; 63: 369-374.

4. Engeli S, Gorzelniak K, Kreutz R et al. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17: 555-560.

5. English V und Cassis L. Fascilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm 1999; 106: 631-644.

6. Enoksson S, Nordenstrom J, Bolinder J. Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes Metab Disord 1995; 19: 350-354.

7. DiGirolamo M, Skinner NS, Hanley HG et al. Relationship of adipose tissue blood flow to fat cell size and number. Int J Physiol 1971; 220: 932-937.

8. Hagström-Toft E, Enoksson S, Moberg E et al. Beta-adrenergic regulation of lipolysis and blood flow in human skeletal muscle in-vivo. Am J Physiol 1998; 275: 909-916.

9. Kelley DE, Goodpaster BH und Storlien L. Muscle triglyceride and insulin. Annu Rev Nutr 2002; 22: 325-346.

10. Tschöp M und Heiman ML. Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes 2001; 109: 307-319.

11. Rayner DV. The sympathetic nervous system in white adipose tissue regulation. Proceed Nutr Soc 2001; 60: 357-364.

12. Engeli S, Schling P, Gorzelniak K et al. The adipose tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. Int J Biochem Cell Biol 2003; 35: 807-825.

13. Forth W, Henschler D, Rummel W (Herausgeber). Allgemeine und spezielle Pharmakologie und Toxikologie, 8. Auflage, Urban und Fischer Verlag 2004.

14. Boschmann M. Heterogeneity of adipose tissue metabolism. In: Klaus S (Herausgeberin), Adipose tissue. Georgetown, TX: Landes Bioscience 2001; 131-157.

15. Enoksson S, Shimizu M, Lönnqvist F et al. Demonstration of an in-vivo functional beta-3-adrenoceptor in man. J Clin Invest 1995; 95: 2239-2245.

16. Lafontan M, Barbe P, Galitzky J et al. Adrenergic regulation of adipocyte metabolism. Hum Reprod 1997; 12: 6-20.

17. Barbe P, Millet L, Galitzky J et al. In situ assessment of the role of the beta 1-, beta 2-, and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 1996; 117: 907-913.

18. Krief S, Lönnqvist F, Raimbault S et al. Tissue distribution of the beta 3-adrenergic in man. J Clin Invest 1993; 91: 344-349.

19. Faintrenie G und Géloen A. Alpha 1-regulation of lactate production by white adipocytes . J Pharm Exp Ther 1996; 277: 235-238.

20. Leibel R und Hirsch J. Site- and sex-related difference in adrenoceptor status of human adipose tissue. J Clin Endocrinol Metab 1987; 64: 1205-1210.

21. Lönnqvist F, Thorne A, Large V et al. Sex differences in visceral fat lipolysis and metabolic complications in obesity. Arterioscler Thromb Vasc Biol 1997; 17: 1472-1480.

22. Boschmann M, Schröder C, Christensen NJ et al. Norepinephrine transporter function and autonomic control of metabolism. J Clin Endocrinol Metab 2002; 87: 5130-5137.

23. Iversen L. Neurotransmitter transporters: Fruitful targets for CNS drug discovery. Mol Psychiatry 2000; 5: 357-362.

24. Galli A, Blakely RD und DeFelice LJ. Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci USA 1996; 93: 8671-8676.

25. Tejani-Butt SM und Yang J. a time course of altered thyroid states on the noradrenergic system in rat brain by quantitative autoradiography. Neuroendocrinology 1994; 59: 235-244.

26. Figlewicz DP. Endocrine regulation of neurotransmitter transporters. Epilepsy Res 1999; 37: 203-210.

27. Shang Y und Dluzen DE. Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats. Neurosci Lett 2002; 328: 81-84.

28. Yang SP, Pau KY und Spies HG. Gonadectomy alters tyrosine hydroxylase and norepnephrine transporter mRNA levels in the locus coeruleus in rabbits. J Neuroendocrinol 1997; 9: 763-768.

29. Jacob G und Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 1999; 317: 88-101.

30. Shannon JR, Flattem NL, Jordan J et al. Orthostatic intolerance and tachycardia associated with norepinephrine transporter defiency. N Engl J Med 2000; 342: 541-549.

31. Timmermans PBMWM, Wong PC, Chiu AT et al. Angiotensin receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-251.

32. Jones A und Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 2003; 35: 855-866.

33. Schütz S, Le Moullec JM, Corvol P et al. Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol 1996; 149: 2067-2079.

34. Engeli S, Negrel R und Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270-1277.

35. Cassis LA, Marshall DE, Fettinger MJ et al. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol 1998; 274: E867-E876.

36. Brink M, Wellen J und Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressure-independent mechanism. J Clin Invest 1996; 97: 2509-2516.

37. Harrison-Bernard LM, El-Dahr SS, O´Leary DF et al. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999; 33: 340-346.

38. Cassis LA und Dwoskin LP. Presynaptic modulation of neurotransmitter release by endogeneous angiotensin II in brown adipose tissue. J Neural Transm Suppl 1991; 34: 129-137.

39. Cassis LA und Dwoskin LP. Acute and chronic losartan administration: effect on angiotensin II content and modulation of [3H]norepinephrine release from rat interscapular brown adipose tissue. J Neural Transm Gen Sect 1994; 98: 159-164.

40. Cabassi A, Coghi P, Govoni P et al. Sympathetic modulation by carvediol and losartan reduces angiotensin II - mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab 2005; 90: 2888-2897.

41. Axelrod L, Minnich AK und Ryan CA. Stimulation of prostacyclin production in isolated rat adipocytes by angiotensin II, vasopressin, and bradykinin: evidence for two separate mechanisms of prostaglandin synthesis. Endocrinology 1985; 116: 2548-2553.

42. Darimont C, Vassaux G, Gaillard D et al. In situ microdialysis of prostaglandins in adipose tissue: stimulation of PGI2 release by angiotensin II. Int J Obes 1994; 18: 783-788.

43. Adams F, Klaus S und Boschmann M. Metabolic and hemodynamic response to angiotensin II in rat adipose tissue (Abstract). Int J Obes Relat Metab Disord 2000; 24.

44. Jones BH, Standridge MK und Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138: 1512-1519.

45. McGrath BP, Matthews PG, Louis W et al . Double blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension. J Cardiovasc Pharmacol 1990; 16: 831-838.

46. Campbell DJ, Duncan AM, Kladis A et al. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1995; 26: 426-436.

47. Goossens GH, Blaak EE, Saris WHM et al. Angiotensin II induced effects on adipose tissue and skeletal muscle blood flow and lipolysis in normal-weight and obese subjects. J Clin Endo Metab 2004; 89: 2690-2696.

48. Shiuchi T, Iwai M, Li HS et al. Angiotensin II type 1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic rats. Hypertension 2004; 43: 1003-1010.

49. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 2004; 30: 498-505.

50. Schoonen AJM und Wientjes KJC. A model for transport of glucose in adipose tissue to a microdialysis probe. Diabetes Technology & Therapeutics 2003; 5: 589-598.

51. Daig R, Staiger H und Löffler G. Pathophysiologie des Fettgewebes. Ernährungsumschau 1999; 46: 208-214.

52. Björntorp P und Sjöström L. Number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism 1971; 20: 703-713.

53. Crandall DL, Goldstein BM, Lizzo FH et al. Hemodynamics to obesity: influence of pattern of adipose tissue cellularity. Am J Physiol 1986; 251: 314-319.

54. Blaak EE, van Baak MA, Kemerink GJ et al. Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism 1995; 44: 183-187.

55. Bolinder J, Kerckhoffs DA, Moberg E et al. Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 2000; 49: 797-802.

56. Jansson P, Larsson A, Smith U et al . Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest 1992; 89: 1610-1617.

57. Summers LK, Samra JS, Humphreys SM et al. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci Colch 1996; 91: 679-683.

58. Tomanek RJ, Palmer PJ, Pfeiffer GL et al. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy. Circ Res 1986; 58: 38-46.

59. Després JP, Prud´homme D, Pouliot MC et al. Estimation of deep abdominal adipose tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991; 54: 471-477.

60. Fischer M, Baessler A und Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002; 53: 672-677.

61. Lönnroth P und Smith U. Microdialysis - a novel technique for clinical investigations. J Intern Med 1990; 227: 295-300.

62. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med 1991; 230: 365-373.

63. Jacob J, Gamboa A, Diedrich A et al. Tyramine-induced vasodilation mediated by dopamine contamination: a paradox resolved. Hypertension 2005; 46: 355-359.

64. Gronlund B, Astrup A, Bie P et al . Noradrenalin release in skeletal muscle and in adipose tissue studied by microdialysis . Clin Sci (Lond) 1991; 80: 595-598.

65. Jordan J, Tank J, Christensen NJ et al. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrin Metab 2001; 86: 2803-2810.

66. Boschmann M, Ringel J, Klaus S et al. Metabolic and hemodynamic response of adipose tissue to angiotensin II. Obes Res 2001; 9: 486-491.

67. Grassi G, Seravalle G, Calhoun DA et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90: 248-253.

68. Darimont C, Delansorne R, Paris J et al. Influence of estrogenic status on the lipolytic activity of parametrial adipose tissue in-vivo: an in-situ microdialysis study. Endocrinology 1997; 138: 1092-1096.

69. Knußmann R. Anthropologie. Handbuch der vergleichenden Biologie des Menschen. Band I (1). Fischer Verlag Stuttgart 1988.

70. Holmes C, Eisenhofer G und Goldstein DS. Improved assay for plasma dihydroxyphenyacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1994; 653: 131-138.

71. Goldstein DS, Holmes C, Jacob G et al. Vasodilation during systemic tyramine administration. Circulation 2004; 109: E17-E18.

72. Thompson GE. Dopamine and lipolysis in adipose tissue of the sheep. Quart J Exp Physiol 1984; 69: 155-159.

73. Nisoli E, Tonello C, Memo M et al. Biochemical functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis. J Pharmacol Exp Ther 1992; 263: 823-829.

74. Hickner RC, Rosdahl H, Borg I et al. The ethanol technique of monitoring local blood flow in rat skeletal muscle: implications for microdialysis. Acta Physiol Scan 1992; 146: 87-97.

75. Karpe F, Fielding BA, Ilic V et al. Monitoring adipose tissue blood flow in man: a comparison between the (133)xenon washout method and microdialysis. Int J Obes Relat Metab Disord 2002; 26: 1-5.

76. Hickner RC, Bone D, Ungerstedt U et al. Muscle blood flow during intermittent exercise: comparison of the microdialysis ethanol technique and (133)Xe clearance. Clin Sci 1994; 86: 15-25.

77. Hickner RC. Microdialysis in skeletal muscle: development and application of the microdialysis ethanol technique (Thesis). Stockholm, Karolinska Institutet 1995.

78. Arner P, Liljeqvist L und Ostman J. Metabolism of mono- and diacylglycerols in subcutaneous adipose tissue of obese and normal-weight subjects. Acta Med Scand 1976; 200: 187-194.

79. Steinberg D, Vaughan M und Margolis S. Studies of triglyceride-biosynthesis in homogenates of adipose tissue. J Biol Chem 1961; 236: 1631-1637.

80. Jansson PA, Smith U und Lönnroth P. Evidence for lactate production by human adipose tissue in vivo. Diabetologia 1990; 33: 253-256.

81. Lafontan M und Arner P. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. Current Techniques 1996; 17: 309-313.

82. Bolinder J, Ungerstedt U und Arner P. Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients. Diabetologia 1992; 35: 1177-1180.

83. Rosdahl H, Hamrin K, Ungerstedt U et al. Metabolites levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol 1998; 274: E936-E945.

84. Rodbell M. Metabolism in isolated fat cells. J Biol Chem 1964; 239: 375-380.

85. Rebuffe-Scrive M, Eldh J, Hafstrom LO et al . Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause. Metabolism 1986; 35: 792-797.

86. Janke J, Engeli S, Gorzelniak K et al. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptor. Diabetes 2002; 51: 1699-1707.

87. Morimoto C, Kameda K, Tsujita T et al. Relationship between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. J Lipid Res 2001; 42: 120-127.

88. Krebs HA. Hoppe-Seyler´s Z. Physiol Chem 1932; 210: 33-66.

89. Jolly SR, Lombardo YB, Lech JJ et al. Effect of aging and cellularity on lipolysis in isolated mouse fat cells. J Lipid Res 1980; 21: 44-52.

90. Hartmann AD, Cohen AL, Richane C et al. Lipolytic response and adenyl cyclase activity of rat adipocytes as related to cell size. J Lipid Res 1971; 12: 498-505.

91. Bernt E und Gutmann I. Ethanol determination with alcohol dehydrogenase and NAD. Bergmeyer HU (Hersg.), Methods of enzymatic analysis, Verlag Chemie 1974; 1499-1505.

92. Felig P. Amino acid metabolism in man. Annu Rev Biochem 1975; 44: 933-955.

93. Cabassi A, Bergamaschi E und Mutti A. Monitoring norepinephrine levels by microdialysis in the white aipose tissue of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 1995; 22: S83-S85.

94. Bairras C, Ferrand C und Atgie C. Effect of tyramine, a dietary amine, on glycerol and lactate release by isolated adipocytes from old rats. J Physiol Biochem 2003; 59: 161-167.

95. Arner P, Kriegholm E und Engfeldt P. In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis. J Pharmacol Exp Ther 1990; 254: 284-288.

96. Arner P, Kriegholm E und Engfeldt P. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. J Pharmacol Exp Ther 1991; 259: 317-322.

97. Galitzky J, Lafontan M, Nordenstrom J et al. Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue. J Clin Invest 1993; 91: 1997-2000.

98. Boschmann M, Jordan J, Schmidt S et al. Gender-specific response to interstitial angiotensin II in human white adipose tissue. Horm Metab Res 2002; 34: 726-730.

99. Boschmann M, Krupp G, Luft FC et al. In vivo response to alpha-1 adrenoceptor stimulation in human white adipose tissue. Obes Res 2002; 10: 555-558.

100. Quisth V, Enoksson S, Blaak E et al. Major differences in noradrenaline action on lipolysis and blood flow rates in skeletal muscle and adipose tissue in vivo. Diabetologia 2005; 48: 946-953.

101. Millet L, Barbe P, Lafontan M et al. Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue. J Appl Physiol 1998; 85: 181-188.

102. Flechtner-Mors M, Jenkinson CP, Ala A et al. In vivo alpha-1 adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. J Pharmacol Exp Ther 2002; 301: 229-233.

103. Jacob G, Costa F, Vincent S et al. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration. Circulation 2003; 107: 2475-2479.

104. Frisk-Holmberg M und Ostman J. Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking agents. J Pharmacol Exp Ther 1977; 200: 598-605.

105. Hellstrom L, Blaak E und Hagstrom-Toft E. Gender differences in adrenergic regulation of lipid mobilization during exercise. Int Sports Med 1996; 17: 439-447.

106. Schröder C, Adams F, Boschmann M et al. Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. Am J Physiol Regul Integr Comp Physiol 2004; 286: 851-856.

107. Townsend RR. The effects of angiotensin II on lipolysis in humans. Metabolism 2001; 50: 468-472.

108. Hennes MM, O´Shaughnessy IM, Kelly TM et al. Insulin-resistent lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension 1996; 28: 120-126.

109. Ungerstedt U. Microdialysis in normal and injured brain. In: Kinney JM und Tucker HN (Hrsg.). Physiology, Stress, and Malnutrition. New York: Lippincott-Raven Publishers 1997; 361-374.

110. Forssard M, Joukhadar C, Steffen C et al. Paracrine effects of angiotensin-converting enzyme and angiotensin II receptor inhibition on transcapillary glucose transport in humans. Life Sciences 2000; 66: 147-154.

111. Engfeldt P und Cassis L. Subcutaneous adipose tissue blood flow in the abdominal und femoral regions in obese women: effect of fasting. Int J Obes Relat Metab Disord 1992; 16: 875-879.

112. Kucmarski RJ, Fanelli MT und Koch GG. Ultrasonic assessment of body composition in obese adults: overcoming the limitations of the skin fold caliper. Am J Clin Nutr 1987; 45: 717-724.

113. Larsen OA, Lassen NA und Quaade F. Blood flow through human adipose tissue determined with radioactive xenon . Acta Physiol Scand 1966; 66: 337-345.

114. Nielsen SL und Larsen OA. Relationship of subcutaneous adipose tissue blood flow to thickness of subcutaneous tissue and total body fat mass. Scand J Clin Lab Invest 1973; 31: 383-388.

115. Bolinder J, Hagström E, Ungerstedt U et al. Microdialysis of subcutaneous adipose tissue in vivo for contineous glucose monitoring in man. Scand J Clin Lab Invest 1989; 49: 465-474.

116. Lönnroth P, Jansson PA, Fredholm BB et al. Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans. Am J Physiol 1989; 256: E250-E255.

117. Felländer G, Linde B und Bolinder J. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 1996; 20: 220-226.

118. Lieber CS. Metabolic aspects of alcoholism. MTP, Lancaster 1977; 1-29:

119. Puddey IB, Zilkens RR, Croft KD et al. Alcohol and endothelial function: a brief review. Clin Exp Pharmacol Physiol 2001; 28: 1020-1024.

120. Strindberg L und Lönnroth P. Validation of an endogeneous reference technique for the calibration of microdialysis catheters. Scand J Clin Lab Invest 2000; 60: 205-211.

121. Orphanidou C, McCargar L, Birmingham CL et al. Accuracy of subcutaneous fat measurement: comparison of skin fold calipers, ultrasound, and computed tomography. J Am Diet Assoc 1994; 94: 855-858.

122. Wofford MR und Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10: 3621-3637.

123. Regan CJ, Duckworth R, Fairhurst JA et al. Metabolic effects of low-dose dopamine infusion in normal volunteers. Clin Sci 1990; 79: 605-611.

124. Nyholm D, Nilsson Remahl AI, Dizdar N et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 2005; 64: 216-223.

125. Palhagen S, Lorefalt B, Carlsson M et al. Does l-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson´s disease? Acta Neurol Scand 2005; 111: 12-20.

126. Gurr MI, Jung RT, Robinson MP et al. Adipose tissue cellularity in man: the relationship between fat cell size and number, the mass and distribution of body fat and the history of weight gain and loss. Int J Obes 1982; 6: 419-436.

127. Knittle JL, Timmers K, Ginsberg Fellner F et al. The growth of adipose tissue in children and adolescents. Cross sectional and longitudinal studies of adipose cell number and size. J Clin Invest 1979; 63: 239-246.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
20.07.2006